ST
GSK icon

Spot Trading’s GSK GSK Stock Holding History

Spot Trading’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3.19M Buy
62,800
+32,960
+110% +$1.67M 0.05% 481
2017
Q2 		$1.61M Buy
29,840
+7,440
+33% +$397K 0.03% 778
2017
Q1 		$1.18M Buy
22,400
+11,520
+106% +$584K 0.04% 649
2016
Q4 		$524K Sell
10,880
-3,360
-24% -$166K 0.01% 1383
2016
Q3 		$768K Sell
14,240
-14,160
-50% -$776K 0.02% 1243
2016
Q2 		$1.54M Sell
28,400
-15,920
-36% -$839K 0.03% 839
2016
Q1 		$2.25M Sell
44,320
-128,880
-74% -$6.42M 0.04% 622
2015
Q4 		$8.74M Buy
173,200
+111,120
+179% +$5.66M 0.09% 279
2015
Q3 		$2.98M Sell
62,080
-10,400
-14% -$541K 0.03% 825
2015
Q2 		$3.77M Buy
72,480
+58,000
+401% +$3.27M 0.03% 724
2015
Q1 		$835K Sell
14,480
-144,800
-91% -$8.3M 0.01% 1732
2014
Q4 		$8.51M Buy
159,280
+1,840
+1% +$103K 0.05% 507
2014
Q3 		$9.05M Buy
157,440
+40,640
+35% +$2.49M 0.04% 584
2014
Q2 		$7.81M Sell
116,800
-5,840
-5% -$395K 0.04% 687
2014
Q1 		$8.19M Buy
122,640
+83,840
+216% +$5.67M 0.05% 560
2013
Q4 		$2.59M Buy
38,800
+2,960
+8% +$192K 0.01% 1334
2013
Q3 		$2.25M Sell
35,840
-53,040
-60% -$3.41M 0.01% 1277
2013
Q2 		$5.55M Buy
+88,880
New +$5.64M 0.03% 652

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Spot Trading's GSK Position: Q3 2017 in Review

Spot Trading sold out of GSK (GSK) in Q3 2017, closing a stake of 1,827 shares — an estimated $92.7K sold.

Spot Trading first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $4.61M in Q3 2014. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Spot Trading reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 1,827 GSK shares in Q3 2017, an estimated $92.7K.
  • Spot Trading first reported a position in GSK in Q2 2013 and held it in 14 quarters.
  • Spot Trading's GSK position peaked at $4.61M in Q3 2014.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.